Intravenous thrombolytic treatment leads to higher independent functional outcome at end of compared with standard medical care (high certainty).
Intravenous thrombolytic treatment showed no clear difference in symptomatic intracranial haemorrhage at compared with standard medical care (high certainty).
Intravenous thrombolytic treatment showed no clear difference in death at compared with standard medical care (high certainty).
Endovascular treatment leads to higher independent functional outcome at end of compared with standard medical care (high certainty).
The review found no eligible studies for this question.
Endovascular treatment showed no clear difference in death at compared with standard medical care (high certainty).
Percutaneous vascular interventions showed no clear difference in good functional outcome (mRS score 0‐2) compared with intravenous thrombolytic treatment (low certainty).
Percutaneous vascular interventions showed no clear difference in death compared with intravenous thrombolytic treatment (low certainty).
Percutaneous vascular interventions showed no clear difference in symptomatic intracranial haemorrhage within first 14 days compared with intravenous thrombolytic treatment (low certainty).
The review found no eligible studies for this question.